{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:42Z","timestamp":1787635122469,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0510034 , JP25ek0510046"],"award-info":[{"award-number":["JP23ek0510034 , JP25ek0510046"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11515"],"award-info":[{"award-number":["24K11515"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Effective risk stratification is vital for donor selection and treatment strategies in allogeneic hematopoietic stem cell transplantation (HSCT). We developed a prediction model for mid- to long-term outcomes after HSCT using a stacked ensemble model (SEM). Using data from the Japanese Transplant Registry Unified Management Program, we analyzed 14,430 patients alive without chronic GVHD (cGVHD) or relapse on day 100 after their first HSCT for hematologic malignancies between 2010 and 2018, predicting 24-month outcomes from pretransplant variables and posttransplant acute GVHD (aGVHD) information, including its treatment, accrued by days 30, 60, and 100. Data were randomly divided into training (80%) and validation (20%) sets, with 14 pretransplant risk factors as input variables. SEM achieved the highest C-index across evaluated endpoints, cGVHD, non-relapse mortality (NRM), and all-cause mortality (ACM), significantly exceeding the weaker learners for all endpoints and, using pretransplant factors, the strongest learner for NRM and ACM as well (both p=0.01), with a smaller, non-significant margin for cGVHD (C-index for cGVHD\/NRM\/ACM\u2014SEM: 0.574\/0.652\/0.642, Cox-PH: 0.553\/0.635\/0.615, Random Survival Forest: 0.564\/0.638\/0.613, XGBoost: 0.556\/0.633\/0.627, Dynamic-DeepHit: 0.508\/0.607\/0.564). The C-index increased as posttransplant aGVHD information accrued (day 30: 0.581\/0.655\/0.649; day 60: 0.602\/0.688\/0.656; day 100: 0.606\/0.696\/0.664). Grade III to IV aGVHD showed predictive contribution to NRM, ultimately impacting ACM. Our SEM-based model offers a useful framework for predicting post-HSCT outcomes and highlights the critical impact of early aGVHD events on long-term prognosis.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1883360","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:09Z","timestamp":1787631789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a stacked ensemble model for risk stratification of chronic GVHD after allogeneic HSCT: Japanese nation-wide cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Makoto","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Defense Medical College","place":["Tokorozawa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Dokkyo Medical University School of Medicine","place":["Tochigi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[{"name":"Japanese Data Center for Hematopoietic Cell Transplantation","place":["Nagakute, Japan"]},{"name":"Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine","place":["Nagakute, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital","place":["Nagoya, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kanagawa Cancer Center","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Tochigi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hamanomachi Hospital","place":["Fukuoka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hyogo Medical University Hospital","place":["Nishinomiya, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Jichi Medical University Saitama Medical Center","place":["Saitama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Anjo Kosei Hospital","place":["Anjo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Tokai University School of Medicine","place":["Isehara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Chiba University","place":["Chiba, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Tottori University","place":["Yonago, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tabuchi","sequence":"additional","affiliation":[{"name":"Japanese Data Center for Hematopoietic Cell Transplantation","place":["Nagakute, Japan"]},{"name":"Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine","place":["Nagakute, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04955.x","article-title":"Validation and extension of the EBMT risk score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants: Validation and extension of a transplant risk score in CML","volume":"125","author":"Passweg","year":"2004","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: A task force report from the National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: Biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90593","article-title":"Cytokine mediators of chronic graft-versus-host disease","volume":"127","author":"MacDonald","year":"2017","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.02.008","article-title":"A multiparameter prognostic risk score of chronic graft-versus-host disease based on CXCL10 and plasmacytoid dendritic cell levels in the peripheral blood at 3 months after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Chirumbolo","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005800","article-title":"Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning","volume":"6","author":"Iwasaki","year":"2022","journal-title":"Blood Adv"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013442","article-title":"Associations between acute and chronic graft-versus-host disease","volume":"8","author":"Tamaki","year":"2024","journal-title":"Blood Adv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1613\/jair.614","article-title":"Popular ensemble methods: An empirical study","volume":"11","author":"Opitz","year":"1999","journal-title":"jair"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxu010","article-title":"Random survival forests for competing risks","volume":"15","author":"Ishwaran","year":"2014","journal-title":"Biostatistics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2019.2909027","article-title":"Dynamic-DeepHit: A deep learning approach for dynamic survival analysis with competing risks based on longitudinal data","volume":"67","author":"Lee","year":"2020","journal-title":"IEEE Trans BioMed Eng"},{"key":"B16","first-page":"55","article-title":"Breast cancer survivability via AdaBoost algorithms","volume-title":"Proceedings of the second australasian workshop on health data and knowledge management - volume 80","author":"Thongkam","year":"2008"},{"key":"B17","unstructured":"XGBoost: A scalable tree boosting system\n          \n          \n            \n              Chen\n              T\n            \n            \n              Guestrin\n              C\n            \n          \n          San Francisco California USA\n          ACM\n          Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining\n          \n          2016"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10994-006-6226-1","article-title":"Extremely randomized trees","volume":"63","author":"Geurts","year":"2006","journal-title":"Mach Learn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/873595","article-title":"A gradient boosting algorithm for survival analysis via direct optimization of concordance index","volume":"2013","author":"Chen","year":"2013","journal-title":"Comput Math Methods Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2019.2913428","article-title":"HitBoost: Survival analysis via a multi-output gradient boosting decision tree method","volume":"7","author":"Liu","year":"2019","journal-title":"IEEE Access"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8570","article-title":"Graphical calibration curves and the integrated calibration index (ICI) for survival models","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19990915\/30)18:17\/18<2529::aid-sim274>3.0.co;2-5","article-title":"Assessment and comparison of prognostic classification schemes for survival data","volume":"18","author":"Graf","year":"1999","journal-title":"Stat Med"},{"key":"B23","first-page":"61","article-title":"Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods","volume-title":"Advances in Large Margin Classifiers","author":"Platt","year":"1999"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Statist Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.01.024","article-title":"Assessment of individual versus composite endpoints of acute graft-versus-host disease in determining long-term survival after allogeneic transplantation","volume":"25","author":"Magenau","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027287","article-title":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","volume":"145","author":"Hern\u00e1ndez-Boluda","year":"2025","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.09.007","article-title":"Predicting patient death after allogeneic stem cell transplantation for inborn errors using machine learning (PREPAD): A European Society for Blood and Marrow Transplantation Inborn Errors Working Party Study","volume":"29","author":"von Asmuth","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.70117","article-title":"Machine learning algorithm to explore patients with heterogeneous treatment effects of clinically significant CMV infection and non-relapse mortality after HSCT","volume":"6","author":"Toya","year":"2025","journal-title":"EJHaem"},{"key":"B30","unstructured":"Estimating treatment effects with causal forests: An application\n          \n          \n            \n              Athey\n              S\n            \n            \n              Wager\n              S\n            \n          \n          \n          2019"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI195228","article-title":"The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers","volume":"136","author":"Martens","year":"2026","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1883360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:11Z","timestamp":1787631791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1883360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1883360"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1883360","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1883360"}}